Alchemia/Dr Reddy's eye improved returns from fondaparinux process tweaks
This article was originally published in Scrip
Executive Summary
Both Alchemia and commercial partner Dr Reddy's Laboratories are so far remaining mum on what impact their improved production process for fondaparinux may have on the end price or margins of their generic formulations of the injected anticoagulant.